DD on RBCC and answers to other questions posted by the IRP's on this board:
Correction - RBCC is a Coral Farm not a Fish Farm
With respect to AMBS - RBCC has certainly milked the press releases alleging to be a partner with AMBS - none of which has come true. AMBS is incredibly naive to think RBCC could provide them with any funding.
RBCC is NOT a bio-tech company - no management experience, no bio-tech assets, nothing - nada - zilch...
This is nothing more than a one man sham to pump the stock price for unsuspecting dupes.
The claim that as a young OTC company that they are actually producing revenue is true - the company earned a gross profit of $23k during the 9 months ending Dec. 31, 2012. However, this was offset by $813k of G&A - which begs the question, what has shareholders gained in spending $813k on a division which has 2 employees, no biotech assets, and nothing to show for an alleged equity interest in n3D??
also one needs to dig into Glendive Investments - beneficial ownership - a Polish offshore account to hide Robert Federowicz involvement with this gem...
